The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Proton Therapy for Early Stage Breast Cancer
Official Title: Phase II Trial of Lumpectomy and Partial Breast Proton Therapy for Early Stage Breast Cancer
Study ID: NCT00614172
Brief Summary: The purpose of this study is to determine if partial breast proton therapy is effective treatment for early stage breast cancer following lumpectomy.
Detailed Description: Radiation therapy is considered standard treatment for most women with early stage breast cancer following lumpectomy. Post-lumpectomy radiotherapy is a proven treatment that reduces cancer recurrence in the breast and improves survival. When standard whole breast radiation techniques are utilized, portions of the chest wall, lung and heart may also receive significant doses of radiation which can lead to radiation induced complications. Radiation techniques that limit the treatment area to the portion of the breast where the cancer arose can minimize and even eliminate radiation dose to the chest wall, heart and lung. This is called partial breast radiotherapy. This study is designed to evaluate the use of proton beam radiotherapy to deliver partial breast radiotherapy in women with early stage breast cancer.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Loma Linda University Medical Center / James M. Slater MD Proton Treatment Center / Department of Radiation Medicine / 11234 Anderson St., Loma Linda, California, United States
Name: David A. Bush, MD
Affiliation: Loma Linda University Department of Radiation Medicine
Role: PRINCIPAL_INVESTIGATOR
Name: Jerry D. Slater, MD
Affiliation: Loma Linda University Department of Radiation Medicine
Role: STUDY_CHAIR